Abdul (Hakkim) R

Abdul (Hakkim) R has a diverse work experience. Abdul (Hakkim) began their career in 2005 at the Max Planck Institute for Infection Biology, where they worked on Neutrophil Extracellular Traps (NETs) as part of their PhD in Immunology. After completing their PhD in 2010, they joined Harvard Medical School as a Research Fellow, where they focused on identifying innate immune strategies and modeling human disease phenotypes using the genetic model organism C. elegans. Abdul (Hakkim) then transitioned to a role as a Research Associate at Harvard Medical School, where they worked until 2018.

In 2017, Abdul co-founded Neutrolis Inc and served as the Founding CEO until 2020. Abdul (Hakkim) then became the Chairman of the company until 2021, and currently holds the position of Co-President and COO.

Abdul (Hakkim) R's education history began in 2005 when they enrolled at the Max Planck Society to pursue a Doctor of Philosophy (PhD) degree in Microbiology and Immunology. Abdul (Hakkim) dedicated five years to completing their PhD program, and in 2010, they graduated from the Max Planck Society.

After obtaining their PhD, Abdul (Hakkim) R continued their academic journey by joining Harvard Medical School as a Research Fellow in Immunology. Abdul (Hakkim) embarked on this new role in 2010 and remained at the institution for five years until 2015.

Overall, Abdul (Hakkim) R's education history showcases their commitment to scientific research and their expertise in the fields of Microbiology and Immunology.